Table 2 Baseline characteristics of the participants who received 2- and 3-dose regimens of hepatitis A vaccine.

Age (years, mean ± SD)

38.1 ± 10.0

39.4 ± 10.4

35.9 ± 9.1

0.115

Type of transplantation

0.219

Living donor kidney transplant

40 (43%)

23 (38.3%)

17 (51.5%)

Deceased donor kidney transplant

53 (57%)

37 (61.7%)

16 (48.5%)

Time post transplantation (months, mean ± SD)

72.70 ± 51.98

78.98 ± 54.78

61.27 ± 45.03

0.116

Immunosuppressive regimen

0.195

Tacrolimus + mycophenolic acid

56 (60.2%)

34 (56.7%)

22 (66.7%)

Tacrolimus minimization with mTOR inhibitor

14 (15.1%)

9 (15.0%)

5 (15.2%)

Cyclosporine

12 (12.9%)

11 (18.3%)

1 (3%)

Calcineurin inhibitor withdrawal

11 (11.8%)

6 (10.0%)

5 (15.2%)

Prednisolone dose (Mean ± SD)

4.26 ± 4.86

4.06 ± 4.52

4.62 ± 5.48

0.598

Creatinine (mg/dL ± SD)

1.38 ± 0.63

1.39 ± 0.70

1.37 ± 0.48

0.906

eGFR (mL/min/1.73 m²)

64.82 ± 21.90

64.22 ± 22.92

65.91 ± 20.23

0.725

Hemoglobin (g/dL, mean ± SD)

12.87 ± 1.93

12.73 ± 1.85

13.12 ± 2.05

0.352

White blood cells count (cells/µL, mean ± SD)

7,159.71 ± 1,932.32

7,284.17 ± 2,001.55

6,930.61 ± 1,806.98

0.401

Percent lymphocyte (%)

29.37 ± 9.87

28.76 ± 10.28

30.48 ± 9.11

0.424

Lymphocyte count (cells/µL, mean ± SD)

2,045.02 ± 744.40

2,026.91 ± 778.05

2,077.93 ± 689.39

0.754

Albumin (g/dL, mean ± SD)

4.21 ± 0.32

4.20 ± 0.29

4.22 ± 0.37

0.748